4.6 Letter

Idelalisib-Rituximab induces clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukaemia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

Richard R. Furman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Hematology

How I treat prolymphocytic leukemia

Claire Dearden

Letter Hematology

Complete response to alemtuzumab in a patient with B prolymphocytic leukemia

Bassem T. Chaar et al.

AMERICAN JOURNAL OF HEMATOLOGY (2007)